Combined administration of antibiotics and direct oral anticoagulants: A renewed indication for laboratory monitoring?

Keyphrases

• Laboratory Monitoring 100%
• Antibiotics 100%
• Combined Administration 100%
• Direct Oral Anticoagulants 100%
• Potential Interaction 40%
• Laboratory Assessment 40%
• Clarithromycin 40%
• Dabigatran 40%
• Anticoagulant Effect 40%
• Cytochrome P450 3A4 (CYP3A4) 40%
• Patient Management 20%
• Low Risk 20%
• Clinical Trials 20%
• Metabolism 20%
• Drug Interactions 20%
• Published Data 20%
• Online Resources 20%
• Resource Base 20%
• Traditional Therapy 20%
• P-glycoprotein (P-gp) 20%
• Thrombotic Events 20%
• Hemorrhagic Disease 20%
• Antibiotic Class 20%
• Laboratory Measurements 20%
• Erythromycin 20%
• Rifampicin 20%
• Dose Adjustment 20%
• Electronic Search 20%
• Information Report 20%
• Cephalosporins 20%
• Fluconazole 20%
• Metronidazole 20%
• Accurate Evaluation 20%
• Social Media Information 20%
• Massive Hemorrhage 20%
• Amoxicillin 20%
• Vitamin K Antagonists 20%
• Anticoagulant Drugs 20%
• Apixaban 20%
• Edoxaban 20%
• Rivaroxaban 20%
• Novel Oral Anticoagulants 20%
• Long-term Anticoagulation 20%
• Phase I Study 20%
• Ketoconazole 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Direct Oral Anticoagulant 100%
• Antibiotics 100%
• Anticoagulant Agent 60%
• Dabigatran 40%
• Clarithromycin 40%
• Metronidazole 20%
• Clinical Trial 20%
• Bleeding 20%
• Glycoprotein 20%
• Antivitamin K 20%
• Rifampicin 20%
• Rivaroxaban 20%
• Apixaban 20%
• Edoxaban 20%
• CYP3A4 20%
• Ketoconazole 20%
• Amoxicillin 20%
• Bioavailability 20%
• Drug Interaction 20%
• Fluconazole 20%
• Erythromycin 20%
• Cephalosporin 20%
• Cytochrome 20%